000			01555 a2200433 4500
005			20250513091037.0
264		0	_c19960718
008			199607s 0 0 eng d
022			_a0007-1188
024	7		_a10.1111/j.1476-5381.1995.tb16398.x _2doi
040			_aNLM _beng _cNLM
100	1		_aMathôt, R A
245	0	0	_aDeoxyribose analogues of N6-cyclopentyladenosine (CPA): partial agonists at the adenosine A1 receptor in vivo. _h[electronic resource]
260			_bBritish journal of pharmacology _cOct 1995
300			_a1957-64 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdenosine _xadministration & dosage
650	0	4	_aAnimals
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBradycardia _xchemically induced
650	0	4	_aDeoxyribose _xanalogs & derivatives
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aIn Vitro Techniques
650	0	4	_aInfusions, Intravenous
650	0	4	_aMale
650	0	4	_aPurinergic P1 Receptor Agonists
650	0	4	_aRats
650	0	4	_aRats, Wistar
650	0	4	_aReceptors, Purinergic P1 _xdrug effects
650	0	4	_aSpecific Pathogen-Free Organisms
650	0	4	_aStructure-Activity Relationship
700	1		_aVan der Wenden, E M
700	1		_aSoudijn, W
700	1		_aIJzerman, A P
700	1		_aDanhof, M
773	0		_tBritish journal of pharmacology _gvol. 116 _gno. 3 _gp. 1957-64
856	4	0	_uhttps://doi.org/10.1111/j.1476-5381.1995.tb16398.x _zAvailable from publisher's website
999			_c8639369 _d8639369